Tanila H, Kauppila T, Taira T
Department of Physiology and Anesthesiology, University of Helsinki, Finland.
Gastroenterology. 1993 Mar;104(3):819-24. doi: 10.1016/0016-5085(93)91018-d.
The effects of selective alpha-agonist medetomidine and alpha 2-antagonist atipamezole on gastrointestinal motility were studied.
The passage of intragastrically administered Evans blue in the small bowel of unanesthetized rats was followed, and the stomachs were weighted after killing the rats.
Subcutaneous medetomidine, 0.01-0.1 mg/kg, was found to delay small intestinal transit but not gastric emptying, with a maximal effect seen at 0.03 mg/kg. Atipamezole fully reversed the effect of 0.1 mg/kg of medetomidine with a dose of 2.5 mg/kg. Atipamezole alone did not affect small intestinal transit. Subcutaneous morphine, 6 mg/kg, delayed gastric emptying and small intestinal transit, whereas intraperitoneal morphine only delayed gastric emptying. Subcutaneous atipamezole, 0.06 mg/kg, was partially able to reverse the delayed intestinal transit but did not inhibit morphine-induced gastric retention. Subcutaneous atipamezole, 0.06 mg/kg, reversed laparotomy-induced ileus completely.
Atipamezole may provide a useful treatment for postlaparotomy ileus.
研究了选择性α-激动剂美托咪定和α2-拮抗剂阿替美唑对胃肠动力的影响。
追踪未麻醉大鼠小肠内胃内给予伊文思蓝后的通过情况,并在处死大鼠后称胃的重量。
发现皮下注射0.01 - 0.1毫克/千克的美托咪定可延迟小肠转运,但不影响胃排空,在0.03毫克/千克时可见最大效应。阿替美唑以2.5毫克/千克的剂量可完全逆转0.1毫克/千克美托咪定的作用。单独使用阿替美唑不影响小肠转运。皮下注射6毫克/千克吗啡可延迟胃排空和小肠转运,而腹腔注射吗啡仅延迟胃排空。皮下注射0.06毫克/千克阿替美唑可部分逆转延迟的小肠转运,但不抑制吗啡诱导的胃潴留。皮下注射0.06毫克/千克阿替美唑可完全逆转剖腹术后肠梗阻。
阿替美唑可能为剖腹术后肠梗阻提供一种有效的治疗方法。